ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,300,000 | -25.3% | 2,500,000 | -28.6% | 0.01% | -33.3% |
| Q2 2023 | $1,739,150 | +23.9% | 3,500,000 | 0.0% | 0.01% | +28.6% |
| Q1 2023 | $1,403,850 | -27.1% | 3,500,000 | 0.0% | 0.01% | -50.0% |
| Q4 2022 | $1,925,000 | -2.3% | 3,500,000 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $1,971,000 | +1.7% | 3,500,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $1,938,000 | +7.4% | 3,500,000 | 0.0% | 0.01% | +80.0% |
| Q1 2022 | $1,805,000 | -2.2% | 3,500,000 | 0.0% | 0.01% | +66.7% |
| Q4 2021 | $1,846,000 | – | 3,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 17,454,000 | $9,826 | 3.09% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,008,250 | 0.99% |
| DCF Advisers, LLC | 3,600,000 | $1,476,000 | 0.90% |
| Context Capital Management, LLC | 21,851 | $8,764 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 32,000,000 | $13,120 | 0.48% |
| SILVERBACK ASSET MANAGEMENT LLC | 6,250,000 | $2,500,000 | 0.34% |
| WHITEBOX ADVISORS LLC | 20,600,000 | $8,159,660 | 0.28% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,425,000 | $11,431,748 | 0.23% |
| READYSTATE ASSET MANAGEMENT LP | 5,500,000 | $2,206,050 | 0.20% |
| DAVIDSON KEMPNER PARTNERS | 25,000,000 | $9,432,500 | 0.18% |